Mirror Syndrome Combined with Postpartum Hemolytic Uremic Syndrome.

IF 0.7 4区医学 Q4 MEDICAL LABORATORY TECHNOLOGY Clinical laboratory Pub Date : 2024-07-01 DOI:10.7754/Clin.Lab.2024.240229

Ning Luo, Hong J Li, Zhu Lin, Yin Li, Hong M Gao

{"title":"Mirror Syndrome Combined with Postpartum Hemolytic Uremic Syndrome.","authors":"Ning Luo, Hong J Li, Zhu Lin, Yin Li, Hong M Gao","doi":"10.7754/Clin.Lab.2024.240229","DOIUrl":null,"url":null,"abstract":"Background: Mirror syndrome is a rare disease characterized by \"triple edema\", while Hemolytic Uremic Syndrome (PHUS) is a serious disease that occurs within a short period of time after the end of pregnancy, with a low prevalence and poor prognosis, and it is even rarer for both to occur in the same patient.Methods: We report a case of mirror syndrome combined with PHUS and analyze the clinical data to improve the understanding of the disease.Results: The patient presented clinically with \"triple edema\" and was diagnosed with mirror image syndrome. After cesarean section, the patient developed cardiac insufficiency, renal insufficiency, hemolysis, and other symptoms and was diagnosed as PHUS. After active treatment, the maternal prognosis was good.Conclusions: Mirror syndrome and PHUS are both clinically rare diseases with poor long-term prognosis if not diagnosed and treated in a timely manner; therefore, awareness of the diseases, early and accurate diagnosis and timely and correct treatment should be improved.","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.240229","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Mirror syndrome is a rare disease characterized by "triple edema", while Hemolytic Uremic Syndrome (PHUS) is a serious disease that occurs within a short period of time after the end of pregnancy, with a low prevalence and poor prognosis, and it is even rarer for both to occur in the same patient.

Methods: We report a case of mirror syndrome combined with PHUS and analyze the clinical data to improve the understanding of the disease.

Results: The patient presented clinically with "triple edema" and was diagnosed with mirror image syndrome. After cesarean section, the patient developed cardiac insufficiency, renal insufficiency, hemolysis, and other symptoms and was diagnosed as PHUS. After active treatment, the maternal prognosis was good.

Conclusions: Mirror syndrome and PHUS are both clinically rare diseases with poor long-term prognosis if not diagnosed and treated in a timely manner; therefore, awareness of the diseases, early and accurate diagnosis and timely and correct treatment should be improved.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

镜像综合征合并产后溶血性尿毒症。

背景：镜像综合征是一种以 "三重水肿 "为特征的罕见疾病，而溶血性尿毒症（PHUS）是一种在妊娠结束后短时间内发生的严重疾病，发病率低且预后差，两者同时发生在同一患者身上更是罕见：方法：我们报告了一例镜像综合征合并 PHUS 的病例，并对临床数据进行了分析，以加深对该疾病的理解：患者临床表现为 "三重水肿"，被诊断为镜像综合征。剖宫产术后，患者出现心功能不全、肾功能不全、溶血等症状，被诊断为 PHUS。经过积极治疗，产妇预后良好：结论：镜像综合征和 PHUS 都是临床罕见病，如不及时诊断和治疗，长期预后不良；因此，应提高对这两种疾病的认识，早期准确诊断，及时正确治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical laboratory 医学-医学实验技术

CiteScore

1.50

自引率

0.00%

发文量

494

审稿时长

3 months

期刊介绍： Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.